Porterhouse Medical announces expansion into the US

  

6 November 2017; Reading, UK – UK-based Porterhouse Medical Ltd is delighted to announce the opening of a subsidiary in Philadelphia, PA, USA. The new entity, Porterhouse Medical US, is to be headed by two experienced medical communications professionals, with a long track record of leading successful businesses in the US.  

Gordon Muir-Jones CMPP, President of Porterhouse Medical US, has, for over 30 years, been directly involved in the development and implementation of multiple global and domestic medical communication plans, with education, publication, training and advocacy components. With particular expertise in publication planning, he is a Charter Member of ISMPP, an active Committee Member, and previous faculty member and expert panelist at TIPPA. Prior to setting up Porterhouse Medical US, Gordon established a US presence for another successful global medical communications consultancy.  

Kevin Ryder PhD, Senior Vice President, has 15 years of experience leading medical communication teams. Also an active member of ISMPP, Kevin has led workshops and panel discussions at national meetings and also served on various committees. Kevin received his doctoral and postdoctoral training in the USA from State University of New York at Stony Brook and Johns Hopkins Medical School, respectively. He held faculty or administrative positions in academic, governmental and non-profit sectors before joining the medical communications field.  

Gordon and Kevin will work closely with the joint managing directors of Porterhouse Medical Ltd, Brian Parsons and Jon Hallows, and will have access to a large and experienced team of scientific staff, client service teams, events managers and creatives. Services will include medical writing, publication planning, insights, creative, events, strategy, health economics and market access.  

Gordon said, “This is an exciting opportunity for both Kevin and I, as well as for Brian and Jon, and the teams based in the UK. Porterhouse is an outstanding independent agency with a passion for quality and integrity and a set of values to which we all subscribe. Establishing a foothold in the US will provide the company with many more opportunities to work closely with clients that share the same ideals and standards.”

Brian added, “Jon and I had an immediate rapport with Gordon and Kevin and share the same vision for the growth and direction of the Porterhouse Medical Group. The establishment of a subsidiary in the US will help our business reach its potential more rapidly and give our staff more opportunities to address new challenges on a global scale.”  

About Porterhouse Medical Ltd
Established in 2002, Porterhouse Medical Ltd is a scientific and medical communications agency with a reputation for excellence. Our in-house teams of carefully selected scientific staff, account managers, and creatives work hard to deliver imaginative and intelligent communications solutions for a growing number of global pharmaceutical partners based in Europe and the US.  

Our services include: • Medical writing • Publication planning • Insights • Creative • Events • Strategy • Health economics • Market access  

Why do clients choose Porterhouse Medical? Watch our video to find out about our company values, the importance of our people and why our clients love to work with us: http://www.porterhouse.biz/index.php/about?vid=237  

Contacts:
Porterhouse Medical Ltd
Contact: Jane Rodgers
jane@porterhouse.biz
Tel: +44 118 913 9100 Porterhouse Medical Ltd, 4 Windsor Square, Silver St, Reading RG1 2TH, UK  

Porterhouse Medical US
Contact: Gordon Muir-Jones
gordon.muir-jones@porterhousemedical.com  
Tel: +1 484 808 4477 Porterhouse Medical US, 1,150 First Avenue, Suite 559, King of Prussia, PA 19406, USA  

Abbreviations
ISMPP, International Society for Medical Publication Professionals
TIPPA, The International Publication Planning Association.